Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.58 |
| ▸ | PRKCA | P17252 | 2/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | MGLL | Q99685 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1196461 | 0.97 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL24763498 | 0.93 | MGLL (0.60) | DGKAMGLLCNR2LMNAMAPT | |
| SCHEMBL9724219 | 0.92 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL9724215 | 0.92 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2701959 | 0.91 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2700406 | 0.91 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2703280 | 0.91 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL25404017 | 0.91 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2703309 | 0.91 | DGKA (0.58) | DGKAPRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL30304038 | 0.89 | DGKA (0.55) | DGKAPRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6835720-B2 | Sulfated drugs | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2004-12-28 | — | — | US | disclosed |
| EP-0957107-B1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS LTD (JP) | 2004-07-21 | — | — | EP | disclosed |
| WO-2003049672-A2 | METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-06-19 | — | — | WO | disclosed |
| WO-2003041639-A2 | METHODS AND COMPOSITIONS FOR TREATING ROTAVIRUS-MEDIATED DISEASE | MICROBIOTIX, INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| US-20030073664-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-17 | — | — | US | disclosed |
| US-6541461-B2 | Treating viral infection; obtain mamal, administer vircide, monitor response to viricide | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020077472-A1 | Novel compounds having antiviral activity | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 2002-06-20 | — | — | US | disclosed |
| US-6337390-B1 | MONOSACCHARIDE LIPID LINKED TO ANOMERIC CARBON OF SIALIC ACID OR KDN | NISSAN FOOD PRODUCTS CO., LTD. (JP) | 2002-01-08 | — | — | US | disclosed |
| EP-0957107-A1 | NOVEL COMPOUNDS HAVING ANTIVIRAL ACTIVITY | NISSIN FOOD PRODUCTS CO., LTD. (JP) | 1999-11-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077472-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | DGKA 944/4885PRKCA 2030/4885PRKCE 2606/4885 |
| US-20030073664-A1 | Novel compounds having antiviral activity | ST6GAL1, SIGLEC7, NEU2 | DGKA 944/4885PRKCA 2030/4885PRKCE 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.